investorscraft@gmail.com

Intrinsic ValueEgide S.A. (ALGID.PA)

Previous Close0.92
Intrinsic Value
Upside potential
Previous Close
0.92

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Egide S.A. specializes in designing and manufacturing hermetic packages that safeguard and interconnect electronic and photonic chips, serving high-reliability industries such as defense, space, telecommunications, and civil aeronautics. The company’s product portfolio includes ceramic-to-metal and glass-to-metal seals, high-temperature cofired ceramics, and thermal management materials, catering to demanding applications where durability and precision are critical. Egide operates in a niche segment of the hardware and equipment sector, competing with larger multinationals by focusing on specialized, high-margin solutions. Its market position is bolstered by long-standing relationships with defense and aerospace clients, though its small scale limits broader industrial penetration. The company’s reliance on cyclical industries like aerospace and telecom exposes it to macroeconomic volatility, but its technological expertise in hermetic packaging provides a defensible niche.

Revenue Profitability And Efficiency

Egide reported revenue of €36.7 million in FY 2023, but net losses widened to €3.1 million, reflecting margin pressures and operational challenges. The company generated €824,000 in operating cash flow, though capital expenditures of €391,000 suggest limited reinvestment capacity. Negative diluted EPS of €0.19 underscores profitability struggles, likely tied to fixed-cost absorption in a subdued demand environment.

Earnings Power And Capital Efficiency

The company’s negative net income and thin operating cash flow indicate weak earnings power, with capital efficiency constrained by its modest scale. Egide’s focus on high-value hermetic solutions may support margins, but current metrics suggest suboptimal asset utilization, particularly given its €12.96 million debt load relative to €3.2 million in cash reserves.

Balance Sheet And Financial Health

Egide’s balance sheet shows €3.2 million in cash against €13 million in total debt, signaling leveraged financial health. With a market capitalization of €11 million, the company’s equity base is thin, and its ability to service debt hinges on improving operational cash flows. The absence of dividends aligns with its need to preserve liquidity.

Growth Trends And Dividend Policy

Egide’s growth is challenged by recent losses, though its niche products retain relevance in defense and aerospace. No dividends were paid in FY 2023, reflecting a conservative capital allocation strategy focused on stabilizing operations. Long-term growth depends on expanding its customer base beyond cyclical end markets.

Valuation And Market Expectations

Trading at a market cap of €11 million, Egide’s valuation reflects skepticism about its turnaround potential. A beta of 0.277 suggests lower volatility than the broader market, but investors likely await clearer signs of margin recovery and debt reduction before assigning higher multiples.

Strategic Advantages And Outlook

Egide’s technical expertise in hermetic packaging provides a competitive edge, but its small scale and reliance on cyclical industries pose risks. The outlook hinges on operational improvements and potential diversification into adjacent high-growth sectors like renewable energy or medical electronics, where its sealing technologies could find new applications.

Sources

Company filings, Euronext Paris disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount